GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival.
Sette P, Amankulor N, Li A, Marzulli M, Leronni D, Zhang M, Goins WF, Kaur B, Bolyard C, Cripe TP, Yu J, Chiocca EA, Glorioso JC, Grandi P.
Sette P, et al. Among authors: chiocca ea.
Mol Ther Oncolytics. 2019 Oct 24;15:214-222. doi: 10.1016/j.omto.2019.10.005. eCollection 2019 Dec 20.
Mol Ther Oncolytics. 2019.
PMID: 31890868
Free PMC article.